Last updated: 2026-09-09 05:05:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Arcellx, Inc. (ACLX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Arcellx, Inc. (ACLX) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, ACLX traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Arcellx, Inc. (ACLX) moved from $115.10 to $115.07, representing a decline of 0.03% ($0.03).
The stock traded between $114.98 and $115.13 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 3.03 million shares, up versus the previous seven-day period, indicating higher trading activity.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 209 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Arcellx, Inc. (ACLX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.